T-cell surface glycoprotein CD3 zeta chain (CD247) (CD247)

The T-cell receptor-CD3 complex (CD3 zeta chain), also known as CD247, is a fundamental multi-protein assembly on the surface of T lymphocytes responsible for recognizing antigens and initiating the adaptive immune response [1, 2]. It comprises the antigen-binding T-cell receptor (TCR) heterodimer and four signaling subunits: CD3 gamma, delta, epsilon, and the zeta chain homodimer [2, 13]. The CD3 zeta chain is particularly vital as it contains three immunoreceptor tyrosine-based activation motifs (ITAMs) per chain, which serve as the primary docking sites for signaling molecules like ZAP-70 upon phosphorylation by Src family kinases [1, 6]. This signaling cascade triggers T-cell proliferation, differentiation, and the secretion of effector cytokines [3, 6]. In clinical contexts, the CD3 zeta chain is a major focus for immunotherapy and a key component of chimeric antigen receptors (CARs), where its intracellular domain provides the essential activation signal for engineered T cells [3, 17]. Downregulation of CD3 zeta is a common mechanism of immune evasion in various cancers and chronic infections, making its expression level a significant biomarker for immune competence and prognosis [10, 14, 16]. Therapeutic agents targeting the broader TCR-CD3 complex include monoclonal antibodies like teplizumab for autoimmune diseases and bispecific T-cell engagers (BiTEs) for oncology, while CAR-T cell therapies directly utilize the zeta chain's signaling capacity to eradicate malignant cells [12, 13, 21].

Other names

CD247CD3ZCD3-zetaT-cell receptor T3 zeta chainTCRZT3ZCD247 moleculeCD3 zeta chain

Agonistic activation of T-cell signaling; T-cell depletion via antibody-dependent cellular cytotoxicity (ADCC); Intracellular signal transduction in chimeric antigen receptor (CAR) constructs [3, 12, 13, 17].